ADCROZ Trademark

Trademark Overview

On Tuesday, July 9, 2019, a trademark application was filed for ADCROZ with the United States Patent and Trademark Office. The USPTO has given the ADCROZ trademark a serial number of 88506312. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2023. This trademark is owned by ADC Therapeutics SA. The ADCROZ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
adcroz

General Information

Serial Number88506312
Word MarkADCROZ
Filing DateTuesday, July 9, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges 1066
CH
Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Monday, February 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 26, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2022SOU EXTENSION 5 GRANTED
Thursday, June 2, 2022SOU EXTENSION 5 FILED
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 23, 2021SOU EXTENSION 4 GRANTED
Thursday, December 23, 2021SOU EXTENSION 4 FILED
Thursday, December 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 28, 2021SOU EXTENSION 3 GRANTED
Monday, June 28, 2021SOU EXTENSION 3 FILED
Monday, June 28, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 28, 2020SOU EXTENSION 2 GRANTED
Monday, December 28, 2020SOU EXTENSION 2 FILED
Monday, December 28, 2020SOU TEAS EXTENSION RECEIVED
Thursday, May 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020SOU EXTENSION 1 GRANTED
Monday, May 4, 2020SOU EXTENSION 1 FILED
Wednesday, May 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2019ASSIGNED TO LIE
Wednesday, September 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019ASSIGNED TO EXAMINER
Tuesday, July 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2019NEW APPLICATION ENTERED

Related Keywords

adcroz pharmaceutical preparations oncology treatment cancer